Panic disorder and psychoactive substance use in primary care
Transtorno do pânico e uso de substâncias psicoativas na atenção primária
Andressa Jacondino Pires; Camila Corrêa Casanova; Luciana de Avila Quevedo; Karen Jansen; Ricardo Azevedo da Silva
Abstract
Keywords
Resumo
Palavras-chave
References
Viana MC, Andrade LH. Lifetime Prevalence, age and gender distribution and age-of-onset of psychiatric disorders in the São Paulo Metropolitan Area, Brazil: results from the São Paulo Megacity Mental Health Survey. Rev Bras Psiquiatr. 2012;34:249-60.
Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2006;63:415-24.
Diagnostic and Statistical Manual of Mental Disorders - 4th edition (DSM-IV). 1995.
Aronson TA, Logue CM. On the longitudinal course of panic disorder: development history and predictors of phobic complications. Compr Psychiatry. 1987;28:344-55.
Lopes FL, Nascimento I, Zin WA, Valença AM, Mezzasalma MA, Figueira I. Smoking and psychiatric disorders: a comorbidity survey. Braz J Med Biol Res. 2002;35:961-7.
Malbergier A, Oliveira Jr HP. Tobacco dependence and psychiatric comorbity.. Rev Psiquiatr Clín. 2005;32:276-82.
Terra MB, Figueira I, Athayde LD. Fobia social e transtorno de pânico: relação temporal com dependência de substâncias psicoativas. Rev. psiquiatr. Rio Gd. Sul. 2003;25:436-43.
Grant BF, Goldstein RB, Chou SP, Huang B, Stinson FS, Dawson DA. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14:1051-66.
Zvolensky MJ, Cougle JR, Johnson KA, Bonn-Miller MO, Bernstein A. Marijuana use and panic psychopathology among a representative sample of adults. Exp Clin Psychopharmacol. 2010;18:129-34.
Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42:1261-72.
Calheiros PRV, Oliveira MS, Andretta I. Comorbidades psiquiátricas no tabagismo. Aletheia. 2006;23:65-74.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97:1183-94.
Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr. 2000;22:106-15.
Dados com base no Levantamento Sócio Econômico (IBOPE). 2003.
Chocrón Bentata L, Vilalta Franch J, Legazpi Rodríguez I, Auquer K, Franch L. Prevalence of psychopathology at a primary care center. Aten Primaria. 1995;16:586-3..
Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158:1568-78.
Koido K, Traks T, Balõtšev R, Eller T, Must A, Koks S. Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder. Transl Psychiatry. 2012;2:e152.
Al-Haddad MK, Sequeira RP, Nayar U. Neurobiological correlates of panic disorder and agoraphobia. J Postgrad Med. 2001;47:55-61.
Wang PS, Berglund P, Kessler RC. Recent care of common mental disorders in the United States :prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284-92.
Goodwin RD, Stein DJ. Anxiety disorders and drug dependence: evidence on sequence and specificity among adults. Psychiatry Clin Neurosci. 2013;67:167-73.
Martins SS, Keyes KM, Storr CL, Zhu H, Chilcoat HD. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009;103:16-24.
Tanios CY, Abou-Saleh MT, Karam AN, Salamoun MM, Mneimneh ZN, Karam EG. The epidemiology of anxiety disorders in the Arab world: a review. J Anxiety Disord. 2009;23:409-19.
Amering M, Bankler B, Berger P, Griengl H, Windhaber J, Katschnig H. Panic disorder and cigarette smoking behavior. Compr Psychiatry. 1999;40:35-8.
Bernstein A, Zvolensky MJ, Schmidt NB, Sachs-Ericcson N. Developmental course(s) of lifetime cigarette use and panic attack comorbidity: an equifinal phenomenon?. Behav Modif. 2007;31:117-35.
Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, Brook JS. Association between cigarette smoking and anxiety disorders during adolescence and early adulthood. JAMA. 2000;284:2348-51.
Lopes FL, Nascimento I, Zin WA, Valença AM, Mezzasalma MA, Figueira I. Smoking and psychiatric disorders: a comorbidity survey. Braz J Med Biol Res. 2002;35:961-7.
Zvolensky MJ, Lewinsohn P, Bernstein A, Schmidt NB, Buckner JD, Seeley J. Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder. J Psychiatr Res. 2008;42:1017-23.
Karila L, Lowenstein W, Coscas S, Benyamina A, Reynaud M. Complications of cocaine addiction. Rev Prat. 2009;59(6):825-9.
O'Brien MS, Wu LT, Anthony JC. Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse. 2005;40:285-97.
Sareen J, Chartier M, Paulus MP, Stein MB. Illicit drug use and anxiety disorders: findings from two community surveys. Psychiatry Res. 2006;142:11-7.
Marmorstein NR. Anxiety disorders and substance use disorders: different associations by anxiety disorder. J Anxiety Disord. 2012;26:88-94.
Glantz MD, Anthony JC, Berglund PA, Degenhardt L, Dierker L, Kalaydjian A. Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med. 2009;39:1365-77.
Falk DE, Yi HY, Hilton ME. Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders. Drug Alcohol Depend. 2008;94:234-45.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email